🏥 Health
1d ago
Safety of Controversial Vasculitis Drug Bolstered in Dedicated Trial
Source ↗
👁 0
💬 0
(MedPage Today) -- ORLANDO -- Interim results from a prospective trial designed to evaluate safety of avacopan (Tavneos), the embattled drug for antineutrophil cytoplasmic antibody-associated vasculitis (AAV), indicated that the product could...
Comments (0)